Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (581-590 of 850) with videos related to

Pageof 85
Sort By:
Minerva Urology and Nephrology|April 23, 2021
Improving the stratification of intermediate risk prostate cancerLuigi Nocera, Claudia Collà Ruvolo, Lara F Stolzenbach, et al.
European Urology|March 27, 2007
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millenniumFelix K-H Chun, Alberto Briganti, Andrea Gallina, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 25, 2012
Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based studyMarco Bianchi, Quoc-Dien Trinh, Maxine Sun, et al.
European Urology|July 4, 2012
Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomyGiacomo Novara, Vincenzo Ficarra, Raymond C Rosen, et al.
Urologic Oncology|August 30, 2021
Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltrationBenedikt Hoeh, Felix Preisser, Mike Wenzel, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical ProstatectomyMike Wenzel, Felix Preisser, Clarissa Wittler, et al.
Urologic Oncology|May 12, 2015
Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibilityJonas Schiffmann, Philipp Wenzel, Georg Salomon, et al.
Scientific Reports|June 20, 2020
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targetingSergey A Dyshlovoy, Ekaterina K Kudryashova, Moritz Kaune, et al.
Journal of Robotic Surgery|April 23, 2022
Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomyBenedikt Hoeh, Jan L Hohenhorst, Mike Wenzel, et al.
The Journal of Urology|February 11, 2014
Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomyJay T Bishoff, Stephen J Freedland, Leah Gerber, et al.
Pageof 85

Showing results (581-590 of 850) with videos related to

Sort By:
Pageof 85
Minerva Urology and Nephrology|April 23, 2021
Improving the stratification of intermediate risk prostate cancerLuigi Nocera, Claudia Collà Ruvolo, Lara F Stolzenbach, et al.
European Urology|March 27, 2007
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millenniumFelix K-H Chun, Alberto Briganti, Andrea Gallina, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 25, 2012
Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based studyMarco Bianchi, Quoc-Dien Trinh, Maxine Sun, et al.
European Urology|July 4, 2012
Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomyGiacomo Novara, Vincenzo Ficarra, Raymond C Rosen, et al.
Urologic Oncology|August 30, 2021
Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltrationBenedikt Hoeh, Felix Preisser, Mike Wenzel, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical ProstatectomyMike Wenzel, Felix Preisser, Clarissa Wittler, et al.
Urologic Oncology|May 12, 2015
Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibilityJonas Schiffmann, Philipp Wenzel, Georg Salomon, et al.
Scientific Reports|June 20, 2020
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targetingSergey A Dyshlovoy, Ekaterina K Kudryashova, Moritz Kaune, et al.
Journal of Robotic Surgery|April 23, 2022
Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomyBenedikt Hoeh, Jan L Hohenhorst, Mike Wenzel, et al.
The Journal of Urology|February 11, 2014
Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomyJay T Bishoff, Stephen J Freedland, Leah Gerber, et al.
Pageof 85